Phase III randomized trial comparing three platinum-based doublets in advanced non–small-cell lung cancer

F De Marinis, L Crino, C Gridelli, S Ricci… - Journal of clinical …, 2002 - ascopubs.org
PURPOSE: To evaluate whether two commonly used newer platinum-based regimens offer
any advantage over vinorelbine-cisplatin (reference regimen) in response rate for patients …
被引用次数：1230 相关文章

[引用][C] Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer

G Scagliotti, F De Marinis, M Rinaldi, L Crino… - JOURNAL OF …, 2002 - iris.unime.it
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell
lung cancer IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT …

Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer

GV Scagliotti, F De Marinis, M Rinaldi, L Crinò… - Journal of Clinical …, 2002 - cir.nii.ac.jp
< jats: p> PURPOSE: To evaluate whether two commonly used newer platinum-based
regimens offer any advantage over vinorelbine-cisplatin (reference regimen) in response …

Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer

GV Scagliotti, F De Marinis, M Rinaldi… - Journal of Clinical …, 2002 - hero.epa.gov
PURPOSE: To evaluate whether two commonly used newer platinum-based regimens offer
any advantage over vinorelbine-cisplatin (reference regimen) in response rate for patients …

Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.

GV Scagliotti, F De Marinis, M Rinaldi… - Journal of Clinical …, 2002 - europepmc.org
Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell
lung cancer. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC …

Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer

GV Scagliotti, F De Marinis… - Journal of clinical …, 2002 - pubmed.ncbi.nlm.nih.gov
Purpose To evaluate whether two commonly used newer platinum-based regimens offer any
advantage over vinorelbine-cisplatin (reference regimen) in response rate for patients with …

Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.

GV Scagliotti, F DE MARINIS, M Rinaldi, L Crin… - JOURNAL OF …, 2002 - iris.unito.it
PURPOSE: To evaluate whether two commonly used newer platinum-based regimens offer
any advantage over vinorelbine-cisplatin (reference regimen) in response rate for patients …
[PDF] archive.org

[PDF][PDF] Phase III Randomized Trial Comparing Three Platinum-Based Doublets in Advanced Non–Small-Cell Lung Cancer

GV Scagliotti, F De Marinis, M Rinaldi… - Journal of Clinical …, 2002 - scholar.archive.org
Purpose: To evaluate whether two commonly used newer platinum-based regimens offer
any advantage over vinorelbine-cisplatin (reference regimen) in response rate for patients …

[引用][C] Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer

GV SCAGLIOTTI… - Journal of …, 2002 - American Society of Clinical …